Douglas A. Treco - Mar 13, 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
CEO, Director
Signature
/s/ Douglas A Treco
Stock symbol
INZY
Transactions as of
Mar 13, 2024
Transactions value $
$0
Form type
4
Date filed
3/15/2024, 08:30 AM
Previous filing
Jun 9, 2023
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +300K $0.00 300K Mar 13, 2024 Common Stock 300K $5.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 13, 2024 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.